Alfaro, Jackie Mae .

HRN: 13-52-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2022
CEFUROXIME 1.5GM (VIAL)
07/29/2022
07/31/2022
IV
1.5gm
Q8 X 7 Doses
S/P Repeat LTCS For Placenta Previa
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: